Implementing PAT for successful Development of Biopharmaceuticals in the UK

Lead Participant: Glaxosmithkline Plc


Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Lead Participant

Project Cost

Grant Offer

Glaxosmithkline Plc, United Kingdom £1,671,735 £ 265,806


University of Liverpool, United Kingdom £238,099 £ 238,099
University of Strathclyde Viz Royal College of Science & Technology, Glasgow £447,673 £ 447,673
Newcastle University, United Kingdom £319,064 £ 319,064


10 25 50